Surrozen Stock Today
| SRZN Stock | USD 9.88 0.12 1.23% |
Performance5 of 100
| Odds Of DistressOver 76
|
Surrozen is selling at 9.88 as of the 19th of October 2024; that is 1.23 percent increase since the beginning of the trading day. The stock's open price was 9.76. Surrozen has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Surrozen are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of October 2022 and ending today, the 19th of October 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 11th of January 2021 | Category Healthcare | Classification Health Care |
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California. Consonance-Hfw Acq operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 3.21 M outstanding shares of which 49.63 K shares are at this time shorted by private and institutional investors with about 4.24 trading days to cover. More on Surrozen
Moving together with Surrozen Stock
| 0.65 | A | Agilent Technologies Fiscal Year End 18th of November 2024 | PairCorr |
| 0.65 | BMY | Bristol Myers Squibb | PairCorr |
Moving against Surrozen Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Surrozen Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President CEO | Craig MBA | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsSurrozen can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Surrozen's financial leverage. It provides some insight into what part of Surrozen's total assets is financed by creditors.
| |||||
Surrozen (SRZN) is traded on NASDAQ Exchange in USA. It is located in 171 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 and employs 42 people. Surrozen is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 31.67 M. Surrozen conducts business under Biotechnology sector and is part of Health Care industry. The entity has 3.21 M outstanding shares of which 49.63 K shares are at this time shorted by private and institutional investors with about 4.24 trading days to cover.
Surrozen currently holds about 92.69 M in cash with (40.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.64.
Check Surrozen Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Surrozen is $31.67 Million. The majority of Surrozen outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Surrozen to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Surrozen. Please pay attention to any change in the institutional holdings of Surrozen as this could imply that something significant has changed or is about to change at the company. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Surrozen Ownership Details
Surrozen Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Alyeska Investment Group, L.p. | 2024-06-30 | 20.4 K | |
| Geode Capital Management, Llc | 2024-06-30 | 18.7 K | |
| Renaissance Technologies Corp | 2024-06-30 | 12.4 K | |
| Ubs Group Ag | 2024-06-30 | 12 K | |
| Blackrock Inc | 2024-06-30 | 5.7 K | |
| Royal Bank Of Canada | 2024-06-30 | 338 | |
| Wolverine Asset Management Llc | 2024-06-30 | 281 | |
| Bank Of America Corp | 2024-06-30 | 20.0 | |
| Jpmorgan Chase & Co | 2024-06-30 | 7.0 | |
| Nantahala Capital Management, Llc | 2024-06-30 | 374.4 K | |
| Ra Capital Management, Llc | 2024-06-30 | 282.6 K |
Surrozen Historical Income Statement
Surrozen Stock Against Markets
Surrozen Corporate Management
| Charles Williams | Chief Officer | Profile | |
| Roeland Nusse | CoFounder Advisor | Profile | |
| Elizabeth Nguyen | VP Culture | Profile | |
| MS JD | Gen Legal | Profile | |
| Li Yang | Executive Research | Profile | |
| WenChen MD | Chief Officer | Profile | |
| Calvin MD | CoFounder Advisor | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surrozen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. To learn how to invest in Surrozen Stock, please use our How to Invest in Surrozen guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surrozen. If investors know Surrozen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surrozen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (22.49) | Revenue Per Share 6.017 | Return On Assets (0.43) | Return On Equity (1.75) |
The market value of Surrozen is measured differently than its book value, which is the value of Surrozen that is recorded on the company's balance sheet. Investors also form their own opinion of Surrozen's value that differs from its market value or its book value, called intrinsic value, which is Surrozen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surrozen's market value can be influenced by many factors that don't directly affect Surrozen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surrozen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Surrozen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surrozen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.